Cy3 Goat Anti-Human IgG (H+L) Antibody: Precision Detection for Immunoassays

Executive Summary: The Cy3 Goat Anti-Human IgG (H+L) Antibody (APExBIO, SKU K1208) is an affinity-purified, polyclonal secondary antibody designed for sensitive and specific detection of human IgG in immunological assays (product details). Conjugation to Cy3 dye ensures robust fluorescence (excitation 552 nm, emission 565 nm), facilitating detection in ICC/IF, IHC, flow cytometry, and ELISA. Its immunoaffinity purification minimizes cross-reactivity, supporting accurate quantification of human antibodies. Signal amplification is achieved by multiple secondary antibodies binding to a single primary antibody, increasing assay sensitivity. Proper storage (aliquoted, -20°C, light-protected) preserves function and fluorescence for up to 12 months (Zhao et al. 2025).

Biological Rationale

Secondary antibodies targeting human immunoglobulins are essential for indirect immunodetection workflows. Human IgG is a dominant immunoglobulin in serum and is commonly measured to assess immune responses, detect infectious diseases, or monitor therapeutic antibodies (Zhao et al. 2025). The Cy3 Goat Anti-Human IgG (H+L) Antibody is generated by immunizing goats with pooled human immunoglobulins, ensuring broad recognition of human IgG subclasses. Affinity purification by immunoaffinity chromatography retains only high-specificity antibodies, reducing non-specific binding and background signal. Fluorescent labeling with Cy3 dye provides a direct, quantitative optical readout compatible with common fluorescence microscopy and flow cytometry instruments. This approach supports both basic research and translational studies, as demonstrated in infectious disease immunology and antibody therapeutic development (Zhao et al. 2025).

Mechanism of Action of Cy3 Goat Anti-Human IgG (H+L) Antibody

The Cy3 Goat Anti-Human IgG (H+L) Antibody functions as a secondary detection reagent. It binds specifically to the heavy (gamma) and light (kappa and lambda) chains of human IgG, allowing for robust detection across subclasses (IgG1–4). The Cy3 dye is covalently linked to the antibody, enabling fluorescence-based detection. When applied in an immunoassay, multiple Cy3-conjugated secondary antibodies can bind to a single primary human IgG molecule. This multivalency enables signal amplification, increasing assay sensitivity and dynamic range.

The antibody is supplied at 1 mg/mL in a buffer containing 23% glycerol, 1% BSA, and 0.02% sodium azide. Glycerol and BSA stabilize the antibody and fluorescent dye; sodium azide inhibits microbial growth. The product is shipped at 4°C and must be aliquoted and stored at -20°C, protected from light, to maintain functionality for up to 12 months. Avoiding repeated freeze-thaw cycles is essential for preserving both fluorescence and antigen-binding activity (APExBIO).

Evidence & Benchmarks

• Affinity-purified goat polyclonal anti-human IgG (H+L) antibodies show minimal cross-reactivity with non-human IgG in standardized immunoassays (Zhao et al. 2025).
• Cy3-conjugated secondary antibodies enable detection limits down to the low nanogram per milliliter range in ELISA and fluorescence-based platforms (Lab Insights 2023).
• Signal-to-noise ratios in immunofluorescence assays improve by 3–10 fold when using affinity-purified, dye-conjugated secondary antibodies versus crude preparations (Protocol Optimization 2023).
• Storage at -20°C in light-protective conditions preserves Cy3 fluorescence with <10% signal loss after 12 months (Mechanism to Medicine 2024).
• Multiplexed detection using Cy3-labeled antibodies is compatible with other fluorophores (e.g., FITC, Cy5), provided spectral separation and compensation are applied (Next-Gen Signal Amplification 2024).

Applications, Limits & Misconceptions

The Cy3 Goat Anti-Human IgG (H+L) Antibody is validated for:

• Immunocytochemistry/Immunofluorescence (ICC/IF) for protein localization studies.
• Immunohistochemistry on frozen (IHC-Fr) and paraffin-embedded (IHC-P) tissues for tissue-based antigen detection.
• Flow cytometry for quantitative single-cell analysis of human IgG-bound targets.
• ELISA for sensitive quantification of human IgG in serum or other biofluids.

This reagent is not suitable for direct detection of non-human immunoglobulins or for applications requiring enzyme-based (non-fluorescent) detection unless combined with appropriate multiplexing strategies.

Common Pitfalls or Misconceptions

• Using the antibody with primary antibodies from non-human species may lead to poor or no signal due to limited cross-reactivity.
• Exposing the Cy3-labeled antibody to light for prolonged periods causes photobleaching and signal loss.
• Repeated freeze-thaw cycles can denature the antibody and reduce both binding affinity and fluorescence intensity.
• Using incompatible mounting media (e.g., those containing antifade reagents not validated for Cy3) may quench Cy3 fluorescence.
• Improper spectral compensation in multiparameter flow cytometry can cause channel bleed-through and inaccurate quantification.

Workflow Integration & Parameters

For optimal results, dilute the Cy3 Goat Anti-Human IgG (H+L) Antibody 1:200 to 1:1000 (final concentration 1–5 µg/mL) in PBS with 1% BSA. Incubate for 30–60 minutes at room temperature in the dark. Wash samples thoroughly to reduce background. For multiplexed assays, select secondary antibodies conjugated to spectrally distinct fluorophores and perform compensation controls. Aliquot the reagent on first thaw and store at -20°C, shielded from light. Discard aliquots after 12 months or if significant fluorescence loss is observed. For further protocol optimization and troubleshooting, see Optimizing Immunoassays with Cy3 Goat Anti-Human IgG (H+L)—this article details stepwise troubleshooting and workflow integration for ICC, IHC, and ELISA, complementing the mechanistic focus here.

For advanced mechanistic insights, From Mechanism to Medicine: Strategic Leveraging of Cy3 Goat Anti-Human IgG (H+L) Antibody discusses biological rationale and translational applications; this article extends those concepts with explicit experimental parameters and updated evidence benchmarks.

Conclusion & Outlook

The Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO offers robust, reproducible signal amplification for human immunoglobulin detection in diverse immunoassays. Affinity purification, Cy3 conjugation, and stringent quality control enable high specificity, low background, and compatibility with standard laboratory workflows. Ongoing innovations in antibody engineering and multiplexed detection are likely to further increase the utility of Cy3-conjugated secondary antibodies in disease research and clinical diagnostics (Zhao et al. 2025). For a deeper dive into advanced signal amplification strategies, see Next-Gen Signal Amplification; this article provides updated, parameter-rich guidance for current best practices.